[HTML][HTML] 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder… - Annals of …, 2015 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA (N2) and selected IIIB non–small-cell lung cancer …
WEE Eberhardt, C Pöttgen, TC Gauler… - Journal of Clinical …, 2015 - ascopubs.org
Purpose Concurrent chemoradiotherapy with or without surgery are options for stage IIIA
(N2) non–small-cell lung cancer. Our previous phase II study had shown the efficacy of …
(N2) non–small-cell lung cancer. Our previous phase II study had shown the efficacy of …
Cancer screening in the elderly: a review of breast, colorectal, lung, and prostate cancer screening
AA Kotwal, MA Schonberg - The Cancer Journal, 2017 - journals.lww.com
There are relatively limited data on outcomes of screening older adults for cancer; therefore,
the decision to screen older adults requires balancing the potential harms of screening and …
the decision to screen older adults requires balancing the potential harms of screening and …
Institutional clinical trial accrual volume and survival of patients with head and neck cancer
EJ Wuthrick, Q Zhang, M Machtay… - Journal of Clinical …, 2015 - ascopubs.org
Purpose National Comprehensive Cancer Network guidelines recommend patients with
head and neck cancer (HNC) receive treatment at centers with expertise, but whether …
head and neck cancer (HNC) receive treatment at centers with expertise, but whether …
[HTML][HTML] Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a …
M Moehler, J Heo, HC Lee, WY Tak, Y Chao… - …, 2019 - Taylor & Francis
ABSTRACT Pexastimogene devacirepvec (Pexa-Vec) is a vaccinia virus-based oncolytic
immunotherapy designed to preferentially replicate in and destroy tumor cells while …
immunotherapy designed to preferentially replicate in and destroy tumor cells while …
Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study
A Exarchakou, B Rachet, A Belot, C Maringe… - Bmj, 2018 - bmj.com
Objective To assess the effectiveness of the NHS Cancer Plan (2000) and subsequent
national cancer policy initiatives in improving cancer survival and reducing socioeconomic …
national cancer policy initiatives in improving cancer survival and reducing socioeconomic …
European Respiratory Society guideline on various aspects of quality in lung cancer care
This European Respiratory Society guideline is dedicated to the provision of good quality
recommendations in lung cancer care. All the clinical recommendations contained were …
recommendations in lung cancer care. All the clinical recommendations contained were …
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma
N Concin, F Planchamp, NR Abu-Rustum… - International Journal of …, 2021 - ijgc.bmj.com
Background Quality of surgical care as a crucial component of a comprehensive multi-
disciplinary management improves outcomes in patients with endometrial carcinoma …
disciplinary management improves outcomes in patients with endometrial carcinoma …
European cancer organisation essential requirements for quality cancer care (ERQCC): lung cancer
T Berghmans, Y Lievens, M Aapro, AM Baird… - Lung Cancer, 2020 - Elsevier
Abstract European Cancer Organisation Essential Requirements for Quality Cancer Care
(ERQCC) are written by experts representing all disciplines involved in cancer care in …
(ERQCC) are written by experts representing all disciplines involved in cancer care in …
Urban-rural differences in receipt of cancer surgery at high-volume hospitals and sensitivity to hospital volume thresholds
H Ramian, Z Sun, J Yabes, B Jacobs… - JCO Oncology …, 2024 - ascopubs.org
PURPOSE There is strong evidence that hospital volume is associated with improved
outcomes for patients undergoing cancer surgery. Lack of access to high-volume hospitals …
outcomes for patients undergoing cancer surgery. Lack of access to high-volume hospitals …